<?xml version="1.0" encoding="UTF-8"?>
<p>TCM is highly valued by the government of China in their campaign to contain and eradiate SARS-CoV-2. For example, Health Commission in 26 provinces have officially declared that TCM should be used in combination with conventional medicine in the treatment of COVID-19 patients. On 17, February, National Health Commission (NHC) of the People's Republic of China reported that 60,107 confirmed COVID-19 patients (85.20% of total confirmed cases) had been treated with TCM 
 <xref rid="B87" ref-type="bibr">87</xref>. As for March 1, 2020, a total of 303 ongoing clinical trials aiming to evaluate the efficacy and safety of treatments for CoV-19 patients have been launched in China. Among them, 50 trials (16.5%) are about the use of TCM, including 14 cases (4.6%) to examine the effect of combined treatment with TCM and Western medicine. In 22 TCM trials (7.3%), the effect of self-made herbal preparations such as 
 <italic>Xin Guan-1 Formula</italic>, 
 <italic>Xin Guan-2 Formula</italic> and 
 <italic>Qing Yi-4</italic> are examined. In another 14 TCM trials (4.6%), commercially available TCM products such as 
 <italic>Tan Re Qing Injection</italic> and
 <italic> Lian Hua Qing Wen Capsule</italic> are studied (Table 
 <xref rid="T4" ref-type="table">4</xref>).
</p>
